153 related articles for article (PubMed ID: 21715391)
1. PEPtalk: postexposure prophylaxis against varicella in children with cancer.
Bate J; Chisholm J; Heath PT; Breuer J; Skinner R; Manley S; Patel S; Wheatley K; Ramsay M; Kearns PR; Hambleton S
Arch Dis Child; 2011 Sep; 96(9):841-5. PubMed ID: 21715391
[TBL] [Abstract][Full Text] [Related]
2. PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.
Bate J; Baker S; Breuer J; Chisholm JC; Gray J; Hambleton S; Houlton A; Jit M; Lowis S; Makin G; O'Sullivan C; Patel SR; Phillips R; Ransinghe N; Ramsay ME; Skinner R; Wheatley K; Heath PT
Arch Dis Child; 2019 Jan; 104(1):25-29. PubMed ID: 29730641
[TBL] [Abstract][Full Text] [Related]
3. Preventing varicella in children with malignancies: what is the evidence?
Fisher JP; Bate J; Hambleton S
Curr Opin Infect Dis; 2011 Jun; 24(3):203-11. PubMed ID: 21455062
[TBL] [Abstract][Full Text] [Related]
4. PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer - results of a multicentre UK evaluation.
Cuerden C; Gower C; Brown K; Heath PT; Andrews N; Amirthalingam G; Bate J
Arch Dis Child; 2022 Jul; ():. PubMed ID: 35803693
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of oral aciclovir in preventing maternal chickenpox: A comparison with VZIG.
Sile B; Brown KE; Gower C; Bosowski J; Dennis A; Falconer M; Stowe J; Andrews N; Amirthalingam G
J Infect; 2022 Aug; 85(2):147-151. PubMed ID: 35659543
[TBL] [Abstract][Full Text] [Related]
6. Postexposure chickenpox prophylaxis in children with leukaemia: a reply to the recent PEPtalk study and report of a service evaluation in a tertiary paediatric haematology centre in the UK.
Samuelson CV; Rambani R; Vora AJ
Arch Dis Child; 2012 Aug; 97(8):759-60. PubMed ID: 22523432
[No Abstract] [Full Text] [Related]
7. Varicella post-exposure management for pediatric oncology patients.
Costa G; Orbach D; Saulpic J; Sarda-Thibault H; Hanslik T; Brethon B; Tabone MD; Raimbault S; Papillard S; Guillaumat C; Nathanson S; Pellegrino B; Belloy M; Mesples B; Trioche P; Jaber H; Raimondo G; Gilet C; Cohen-Gogo S
Bull Cancer; 2022 Mar; 109(3):287-295. PubMed ID: 35093244
[TBL] [Abstract][Full Text] [Related]
8. Persistence of protective immunity after postexposure prophylaxis of varicella with oral aciclovir in the family setting.
Yoshikawa T; Suga S; Kozawa T; Kawaguchi S; Asano Y
Arch Dis Child; 1998 Jan; 78(1):61-3. PubMed ID: 9534679
[TBL] [Abstract][Full Text] [Related]
9. Varicella postexposure prophylaxis in children with cancer: urgent need for a randomised controlled trial.
Bate J; Chisholm J; Skinner R; Breuer J; Ramsay M; Wheatley K; Hambleton S; Heath PT
Arch Dis Child; 2012 Sep; 97(9):853-4. PubMed ID: 22875905
[No Abstract] [Full Text] [Related]
10. Serum concentrations, efficacy, and safety of a new, intravenously administered varicella zoster immune globulin in pregnant women.
Koren G; Money D; Boucher M; Aoki F; Petric M; Innocencion G; Wolosk M; Remple V; Pelland F; Geist R; Ho T; Bar-Oz B; Loebstein R
J Clin Pharmacol; 2002 Mar; 42(3):267-74. PubMed ID: 11865962
[TBL] [Abstract][Full Text] [Related]
11. VZV infection in pregnancy: a retrospective review over 5 years in Sheffield and discussion on the potential utilisation of varicella vaccine in prevention.
McKendrick MW; Lau J; Alston S; Bremner J
J Infect; 2007 Jul; 55(1):64-7. PubMed ID: 17418420
[TBL] [Abstract][Full Text] [Related]
12. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
[TBL] [Abstract][Full Text] [Related]
13. Acyclovir prophylaxis of varicella in children with renal disease receiving steroids.
Goldstein SL; Somers MJ; Lande MB; Brewer ED; Jabs KL
Pediatr Nephrol; 2000 Apr; 14(4):305-8. PubMed ID: 10775074
[TBL] [Abstract][Full Text] [Related]
14. [Revised multidisciplinary guidelines 'Varicella'; broader indication for post-exposure prophylaxis].
van Kampen JJA; Bruns AHW; van Leeuwen E; Koelewijn JM; Ruijs WLM; Komen DJC; Vermont CL; Opstelten W
Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32779924
[TBL] [Abstract][Full Text] [Related]
15. Neonatal varicella: varicella zoster immunoglobulin (VZIG) does not prevent disease.
Reynolds L; Struik S; Nadel S
Arch Dis Child Fetal Neonatal Ed; 1999 Jul; 81(1):F69-70. PubMed ID: 10375368
[TBL] [Abstract][Full Text] [Related]
16. Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin.
Paryani SG; Arvin AM; Koropchak CM; Dobkin MB; Wittek AE; Amylon MD; Budinger MD
J Pediatr; 1984 Aug; 105(2):200-5. PubMed ID: 6086866
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
Macartney K; Heywood A; McIntyre P
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001833. PubMed ID: 24954057
[TBL] [Abstract][Full Text] [Related]
18. Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection.
Ogilvie MM
J Infect; 1998 Jan; 36 Suppl 1():31-8. PubMed ID: 9514106
[TBL] [Abstract][Full Text] [Related]
19. Varicella in pediatric renal transplant recipients.
Lynfield R; Herrin JT; Rubin RH
Pediatrics; 1992 Aug; 90(2 Pt 1):216-20. PubMed ID: 1322522
[TBL] [Abstract][Full Text] [Related]
20. Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.
Prelog M; Schönlaub J; Zimmerhackl LB
Pediatr Nephrol; 2011 May; 26(5):663-73. PubMed ID: 21076967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
